Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/2008
12/03/2008CN101316592A Indenoisoquinolinone analogs and methods of use thereof
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459414 Herbicides
12/02/2008CA2317444C N-acyl cyclic amine derivatives
11/2008
11/27/2008WO2008144394A2 Fused-ring heterocycle opioids
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008073613A3 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines
11/27/2008WO2008031771A3 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
11/27/2008US20080293763 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/27/2008US20080293685 Spiro and other derivatives of diamondoids possessing therapeutic activity in the treatment of viral disorders
11/27/2008US20080292585 Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
11/27/2008DE102007023747A1 Organisches elektrochromes Bauelement für Daueranzeigen Organic electrochromic device for continuous displays
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2686851A1 Fused-ring heterocycle opioids
11/26/2008CN101311176A Isoquinoline compounds, preparation method and use thereof
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/20/2008WO2007106400A3 Pyridine-containing macroheterocylic compounds as kinase inhibitors
11/20/2008US20080287484 Neurotrophin antagonist compositions
11/20/2008US20080287481 Process for the preparation of desloratadine polymorph mixtures
11/19/2008EP1992629A1 Preparation of levofloxacin and forms thereof
11/19/2008CN100434423C Synthesis method of lappaconitine hydrobromide
11/19/2008CN100434422C Optical isomer of phencynonate and its use in preparing medicine
11/18/2008US7452994 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/13/2008WO2008033930A3 Vinca derivatives
11/13/2008WO2008028168A3 Serine-threonine protein kinase and parp modulators
11/13/2008US20080280936 Morphinan Compounds
11/13/2008US20080280883 Muscarinic Receptor Antagonists
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008CA2809739A1 Morphinan compounds
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1817290B1 Luminescent indicator dye and optical sensor
11/12/2008EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
11/12/2008CN101304973A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101302197A 4- azido-1,8-naphthalimide compound and preparation thereof
11/12/2008CN101302194A Synthetic method of polysubstituted chinoline compound
11/12/2008CN101301370A Method for preparing monoester type alkaloids using Chinese medicinal material of aconitum as raw material
11/12/2008CN100432076C Camptothecine derivative, preparing method and use
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449583 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/06/2008WO2008033935A3 Vinorelbine derivatives
11/05/2008EP1499596B1 Muscarinic antagonists
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008CN100430402C Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
11/05/2008CN100430382C Synthesis method of lappaconitine citrate
11/04/2008US7446198 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides
11/04/2008US7446110 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; benign prostate hyperplasia, depression, sexual dysfuction, sleep apnea; ideal for hormone replacement therapy in hypogonadic men
11/04/2008CA2310458C Piperidine derivatives
10/2008
10/30/2008WO2008129007A1 Benzimidazoles with a hetero spiro-decane residue as npy-y5 antagonists
10/30/2008US20080269485 Fluorinated dyes and their use in electrophoretic display devices
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/29/2008CN101293872A Method for preparing high-purity laurotetanine with high speed reversed flow color spectrum method
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
10/23/2008WO2008125008A1 Cyclohepta[b]pyridine compounds, preparation method and usage thereof as well as pharmaceutical compositions containing the compounds
10/23/2008US20080262231 Cyclization of a bicyclic ketone; water scavenger adjuvant; chemical intermediates for analgesics
10/23/2008US20080262028 Imidazole derivatives as inhibitors of tafia
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080261999 Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008CN101289425A Enantioselective alkylation of tricyclic compounds
10/16/2008US20080255357 Terrylene and Quaterrylene Derivatives
10/16/2008US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability
10/16/2008US20080255178 Azaadamantane Ester and Carbamate Derivatives and Methods of Use Thereof
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008CN100425593C Method for preparing kukoline hydrochloride single-crystal using acid and alkaline method
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/09/2008WO2008121817A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008119797A1 Dinaphthoquaterrylene as a photosensitizer in solar cells
10/09/2008WO2008007262B1 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
10/09/2008US20080249311 Preparation of Clopidogrel and Its Analogues Methyl Tetrahydrothienopyridine Acetate Compuunds
10/09/2008CA2681757A1 Methods and compositions for selectin inhibition
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008CN101282932A Carboxyamine compounds and their use in the treatment of HDAC dependent diseases
10/08/2008CN101279945A Extracting method of valerine
10/08/2008CN101279944A Halogenated cyclopenteno[b]pyridine, preparation and application thereof
10/08/2008CN101279943A Preparation of 6,7-dihydro-5H-cyclopenteno[b] pyridine
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/02/2008US20080242693 dopamine and nicotinic acetylcholine receptors antagonist; analgesic, antidepressant, anxiolytic agent; neurodegenerative diseases, drug and nicotine abuse, obesity; 6-(5-methoxy-3-pyridinyl)-3-azabicyclo[3.3.1]non-6-ene
10/02/2008US20080242692 Synthesis of Indenoisoquinoliniums and Methods of Use
10/02/2008US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands
10/02/2008US20080241416 Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method
10/02/2008US20080241090 Use of Fluorescent Perylene Compounds for the Treatment of Human Hair
10/01/2008EP1975160A1 Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method
10/01/2008EP1973882A1 Piperazine derivatives as farnesyl protein transferase inhibitors
10/01/2008CN101277936A Process for the synthesis of compounds for selectin inhibition
10/01/2008CN101273990A Applications of hetisine type diterpenoid akaloids in preparing medicine for curing or preventing atrial fibrillation
09/2008
09/30/2008US7429666 Pyridine analogs as C5a antagonists
09/30/2008US7429664 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
09/30/2008US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation
09/25/2008US20080234308 Amino-Aza-Adamantane Derivatives and Methods of Use
09/25/2008US20080234305 Novel Tetrahydropyridine Derivatives
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 110